Aids: is the end in sight?

Mass prescription of anti-retroviral drugs could eradicate the disease within 40 years, scientist says

Testing everyone at risk of HIV and treating them with anti-retroviral drugs could eradicate the global epidemic within 40 years, according to the scientist at the centre of a radical new approach to fighting Aids.

An aggressive programme of prescribing anti-retroviral treatment (ART) to every person infected with HIV could stop all new infections in five years and eventually wipe out the epidemic, said Brian Williams of the South African Centre for Epidemiological Modelling and Analysis.

Dr Williams is part of a growing body of experts who believe that anti-HIV drugs are probably the best hope of preventing and even eliminating the spread of Aids, rather than waiting for the development of an effective vaccine or relying solely on people changing their sexual lifestyle.

The idea will be tested in the coming year, with the start of the first properly controlled clinical trial involving thousands of people living in a part of South Africa with a high incidence of HIV and Aids. Dr Williams said this will be followed by similar trials in the US, where HIV is rampant among some inner-city communities.

"Our immediate best hope is to use ART not only to save lives but also to reduce transmission of HIV. I believe if we used ART drugs we could effectively stop transmission of HIV within five years," Dr Williams said. "It may be possible to stop HIV transmission and halve Aids-related TB within 10 years and eliminate both infections within 40 years," he told the American Association for the Advancement of Science in San Diego, California.

Anti-retroviral drugs dramatically lower the concentration of HIV within a person's bloodstream, and, in addition to protecting patients against Aids, they significantly lower an individual's infectiousness – their ability to transmit the virus to another person.

Dr Williams and his supporters believe that if enough infected people are treated, it would lower the rate of infection to such an extent that the epidemic would die out within the lifetime of those undergoing the treatment. Aids could effectively be wiped out by the middle of this century, he said.

"The problem is that we are using the drugs to save lives, but we are not using them to stop transmission," Dr Williams said. Blocking transmission can only be done with an extensive testing regime followed by rapid treatment with anti-retroviral drugs to everyone found to be HIV positive, he said.

"The concentration of the virus drops 10,000 times [with ART] ... This probably translates into a 25-fold reduction in infectiousness. But if you did this it would be enough essentially to stop transmission," he said.

A study published in 2008 showed that it is theoretically possible to cut new HIV cases by 95 per cent, from a prevalence of 20 per 1,000 to 1 per 1,000, within 10 years of implementing a programme of universal testing and prescription of ART drugs.

"Each person with HIV infects, on average, one person every one or two years. Since people with HIV, and without treatment, live for an average of 10 years after infection, each person with HIV infects about five to 10 people," Dr Williams said. "Treating people with ART within about one year of becoming infected would reduce transmission by about 10 times. Each person with HIV would infect, on average, less than one other person and the epidemic would die out."

ART drugs have to be taken on a daily basis for life, and the cost for South Africa alone would be about $4bn (£2.6bn) per year. However, Dr Williams said that the cost of having to treat a growing number of Aids patients, as well as the economic cost of young adults dying off, would be higher than giving out free ART drugs to everyone who needs them.

"The key issue of cost is that if you don't do anything it costs you a lot of money. In South Africa we spend a lot of money on people who are hospitalised with infections related to HIV," Dr Williams said. "More importantly, we are killing young adults in the prime of their life just when they should be contributing to society. The cost to society of that is enormous.

"If you factor all of the costs into the equation then, in my opinion, doing this is a cost saving from day one because the cost of the drugs will be more than outweighed by the costs of treating all of these people with other diseases," he said. "A friend of mine said that the only thing that is more expensive than doing this is not doing this."

The first full-scale clinical trial is being planned in Hlabisa in Somkhele, about 220km north of Durban. It will be designed to test whether it is possible to ensure that people who are taking ART drugs comply with the strict prescription regime of daily pill taking, as well as discovering whether transmission rates fall below the level needed to sustain the epidemic.

"One quarter of the global cases are in southern Africa and one half of these are in South Africa, so South Africa is extraordinarily badly affected," Dr Williams said.

"We could stop transmission quickly, but it doesn't end the problem because people are infected with HIV for life. So we really are in it for the long term. We need to do a lot of operational research before we can consider this seriously as a public-health intervention, but there is a lot of enthusiasm for it," he added.

Suggested Topics
Start your day with The Independent, sign up for daily news emails
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Sheridan Maine: Accounts Assistant

£25,000 - £30,000: Sheridan Maine: Are you looking for a fantastic opportunity...

Neil Pavier: Commercial Analyst

£50,000 - £55,000: Neil Pavier: Are you a professionally qualified commercial ...

Loren Hughes: Financial Accountant

£45,000 - £55,000: Loren Hughes: Are you looking for a new opportunity that wi...

Ashdown Group: IT Support Engineer - Professional Services Firm - Oxford

£21000 - £24000 per annum + 21 days holidays: Ashdown Group: Technical Support...

Day In a Page

No postcode? No vote

Floating voters

How living on a houseboat meant I didn't officially 'exist'
Louis Theroux's affable Englishman routine begins to wear thin

By Reason of Insanity

Louis Theroux's affable Englishman routine begins to wear thin
Power dressing is back – but no shoulderpads!

Power dressing is back

But banish all thoughts of Eighties shoulderpads
Spanish stone-age cave paintings 'under threat' after being re-opened to the public

Spanish stone-age cave paintings in Altamira 'under threat'

Caves were re-opened to the public
'I was the bookies’ favourite to be first to leave the Cabinet'

Vince Cable interview

'I was the bookies’ favourite to be first to leave the Cabinet'
Election 2015: How many of the Government's coalition agreement promises have been kept?

Promises, promises

But how many coalition agreement pledges have been kept?
The Gaza fisherman who built his own reef - and was shot dead there by an Israeli gunboat

The death of a Gaza fisherman

He built his own reef, and was fatally shot there by an Israeli gunboat
Saudi Arabia's airstrikes in Yemen are fuelling the Gulf's fire

Saudi airstrikes are fuelling the Gulf's fire

Arab intervention in Yemen risks entrenching Sunni-Shia divide and handing a victory to Isis, says Patrick Cockburn
Zayn Malik's departure from One Direction shows the perils of fame in the age of social media

The only direction Zayn could go

We wince at the anguish of One Direction's fans, but Malik's departure shows the perils of fame in the age of social media
Young Magician of the Year 2015: Meet the schoolgirl from Newcastle who has her heart set on being the competition's first female winner

Spells like teen spirit

A 16-year-old from Newcastle has set her heart on being the first female to win Young Magician of the Year. Jonathan Owen meets her
Jonathan Anderson: If fashion is a cycle, this young man knows just how to ride it

If fashion is a cycle, this young man knows just how to ride it

British designer Jonathan Anderson is putting his stamp on venerable house Loewe
Number plates scheme could provide a licence to offend in the land of the free

Licence to offend in the land of the free

Cash-strapped states have hit on a way of making money out of drivers that may be in collision with the First Amendment, says Rupert Cornwell
From farm to fork: Meet the Cornish fishermen, vegetable-growers and butchers causing a stir in London's top restaurants

From farm to fork in Cornwall

One man is bringing together Cornwall's most accomplished growers, fishermen and butchers with London's best chefs to put the finest, freshest produce on the plates of some of the country’s best restaurants
Robert Parker interview: The world's top wine critic on tasting 10,000 bottles a year, absurd drinking notes and New World wannabes

Robert Parker interview

The world's top wine critic on tasting 10,000 bottles a year, absurd drinking notes and New World wannabes
Don't believe the stereotype - or should you?

Don't believe the stereotype - or should you?

We exaggerate regional traits and turn them into jokes - and those on the receiving end are in on it too, says DJ Taylor